VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31584561.
- Also identified by DOI 10.1097/IAE.0000000000002656 and PMC identifier 7108969.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To describe patients with intermediate uveitis complicated by vasoproliferative tumors (VPTs). Data were collected at seven Uveitis/Ocular Oncology centers on demographic, ophthalmic findings at baseline and at follow-up, and on imaging. The therapeutic intervention, final visual acuity, and duration of follow-up were recorded. A total of 36 eyes from 34 patients (12 men, 22 women; mean age 35.3 ± 14.2 years) were included in this study. Visual acuity at presentation ranged from 20/40 to counting fingers. At the time of VPT diagnosis, intermediate uveitis was active in all eyes. The mean VPT thickness was 3.06 ± 0.86 mm. Local treatment to the VPT was provide in 22 eyes (61.1%) and no local treatment to the VPT in 14 eyes (38.9%). After the VPT was detected, systemic or local treatment for the inflammation was initiated and on follow-up FAs 94.4% of the eyes showed resolution of the vascular leakage. During follow-up of 35.8 months, the 22 VPTs treated locally had a reduction in the tumor thickness to 1.25 mm, whereas the 14 VPTs untreated remained stable (final mean tumor thickness 2.65 mm). The presence of active intermediate uveitis accompanied by VPTs suggests the need for an aggressive uveitis treatment.
Medical subject headings
- Neoplasms, Vascular Tissue
- Retinal Neoplasms
- Retinal Vessels
- Uveitis, Intermediate